Advanced search
Publication Cover
Cancer Biology & Therapy Volume 20, 2019 - Issue 3
Submit an article Journal homepage
1,977
Views
25
CrossRef citations to date
0
Altmetric
Research Paper

The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study

Zeran Yanga Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Guang Chena Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Ye Cuib Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, ChinaView further author information
,
Guowen Xiaoa Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Tianhao Sua Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Jianan Yua Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Zhiyuan Zhanga Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Yanjing Hana Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Kailan Yanga Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
&
Long Jina Interventional radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 321-327 | Received 09 Apr 2018, Accepted 22 Sep 2018, Published online: 17 Oct 2018

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Qi Liu, Xin Xu & Wei Sun. (2022) Down-regulated HSA_circ_0003528 inhibits hepatocellular carcinoma aggressiveness via the miR-212-3p/XIAP axis. Bioengineered 13:4, pages 11269-11280.
Read now
Weihua Zhang, Lei Chen, Yanyan Cao, Bo Sun, Yanqiao Ren, Tao Sun & Chuansheng Zheng. (2021) Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma. Cancer Management and Research 13, pages 5391-5402.
Read now

Articles from other publishers (23)

Ningjie Li, Ping Yang & Jun Fang. (2022) Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 46:9, pages 102022.
Crossref
Zi-yi Liu, Xue-feng Kan, Li-jie Zhang, Joyman Makamure, Qing Li, Dan Zhao, Guo-feng Zhou, Gan-sheng Feng, Chuan-sheng Zheng & Bin Liang. (2022) Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors. Current Medical Science 42:5, pages 1015-1021.
Crossref
Ran You, Qingyu Xu, Qi Wang, Qingqiao Zhang, Weizhong Zhou, Chi Cao, Xiangzhong Huang, Honghai Ji, Penghua Lv, Hao Jiang, You Lu, Yong Jin, Yongjun Li, Long Cheng, Weidong Wang, Hao Xu, Xiaoli Zhu & Guowen Yin. (2022) Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study. Frontiers in Oncology 12.
Crossref
Zhenzhen Zhang, Yanfang Wu, Tanghui Zheng, Xiaochun Chen, Guobin Chen, Hong Chen, Xinkun Guo, Susu Zheng, Xiaoying Xie & Boheng Zhang. (2022) Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis. Cancers 14:15, pages 3710.
Crossref
Fuhai Hui, Chang Xu, Xiangbo Xu, Jiangxia Chen, Hefeng Geng, Chao Yang & Yingshi Zhang. (2022) What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis. Frontiers in Oncology 12.
Crossref
Zhuangzhuang Zheng, Zijing Liu, Haifeng Zhang, Xiao Guo, Xiaojing Jia, Jianfeng Wang, Lingbin Meng, Ying Xin & Xin Jiang. (2022) Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study. Frontiers in Pharmacology 13.
Crossref
Cheng Chen, Xiaoting Duan, Yanfeng Shen & Guiying Li. (2022) The clinical efficacy and safety of TACE combined with apatinib for advanced hepatocellular carcinoma: A propensity score matching analysis. Indian Journal of Cancer 0:0, pages 0.
Crossref
Shun Liu, Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Xian-Hai Zhu, Bo Jiang, Yu-Lin Tan & Guo-Xiang Wang. (2021) The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma. Frontiers in Medicine 8.
Crossref
Lei Chen, Tao Sun, Linxia Wu, Weihua Zhang, Yanqiao Ren, Dongqiao Xiang, Bin Liang & Chuansheng Zheng. (2021) The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma. Journal of Oncology 2021, pages 1-10.
Crossref
Zhaonan Li, Quanjing Chen, Wenguang Zhang, Guangyan Si, Jing Li, Dechao Jiao & Xinwei Han. (2021) Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-9.
Crossref
Hui Xia, Cheng Zhou, Zhaoxia Luo, Ping Zhang, Liping Zhu & Zhao Gong. (2021) Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer. Frontiers in Oncology 11.
Crossref
源 冯. (2021) Clinical Research Progress of Apatinib in the Treatment of Hepatocellular Carcinoma. Advances in Clinical Medicine 11:12, pages 6195-6200.
Crossref
Yue Ren, Shan-Bing Wang, Lin Zhou, Si-Qiao Liu, Lei-Ya Du, Ting Li, Mao-Qiong Jiang, Kai-Jian Lei, Bang-Xian Tan & Yu-Ming Jia. (2021) Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC. Technology in Cancer Research & Treatment 20, pages 153303382110119.
Crossref
Congcong Ren, Jing Zhao, Lin Kang, Yan Di, Gang Qiu & Qingxue Wang. (2021) Successful treatment of radiotherapy and apatinib in patient with mediastinal mixed non-seminomatous germ cell tumor. Medicine 100:43, pages e27617.
Crossref
Tao Sun, Yanqiao Ren, Xuefeng Kan, Lei Chen, Weihua Zhang, Fan Yang & Chuansheng Zheng. (2020) Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib. Frontiers in Molecular Biosciences 7.
Crossref
Lei Chen, Zunqian Ke, Fu Xiong, Xuefeng Kan, Yanqiao Ren, Yanyan Cao, Tao Sun, Liangliang Yan, Guofeng Zhou & Chuansheng Zheng. (2020) Platelet-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization plus apatinib in the treatment of advanced hepatocellular carcinoma. Anti-Cancer Drugs 31:9, pages 966-972.
Crossref
Chen-Hao Zhang, Ming Li, You-Pei Lin & Qiang Gao. (2020) Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes. Current Gene Therapy 20:2, pages 84-99.
Crossref
Xuefeng Kan, Bin Liang, Guofeng Zhou, Bin Xiong, Feng Pan, Yanqiao Ren, Yanyan Cao, Jihua Wang, Fan Yang & Chuansheng Zheng. (2020) Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Frontiers in Oncology 10.
Crossref
Juanfang Liu, Jianwei Xu, Wenguang Zhang, Jianjian Chen, Xueliang Zhou, Zhaonan Li & Xinwei Han. (2020) Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma. Academic Radiology 27:5, pages 704-709.
Crossref
Yan Liu, Xiao Chen, Xiang Gao, Jing-Xiu Chen & Jie Chen. (2019) Apatinib-induced hyperammonemic encephalopathy. Journal of Oncology Pharmacy Practice 26:2, pages 465-470.
Crossref
Juanfang Liu, Shanshan Xie, Xuhua Duan, Jianjian Chen, Xueliang Zhou, Yahua Li, Zhaonan Li & Xinwei Han. (2019) Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 85:1, pages 69-76.
Crossref
立东 秦. (2019) Efficacy and Safety of Transarterial Chemoembolization Combined with Apatinib Mesylate in Patients with Advanced Hepatocellular Carcinoma. Advances in Clinical Medicine 09:11, pages 1339-1345.
Crossref
Yan Wei, Jianjun Liu, Min Yan, Shuguang Zhao, Yong Long & Weilu Zhang. (2019) Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis. Chemotherapy 64:2, pages 94-104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.